Related stories
Ardelyx reports third-quarter loss of $737,000
M impact | EQUITY | Nov 03, 2026, 09:14 PM UTC
Aquestive Therapeutics Reports Third-Quarter 2026 Financial Results and Business Update
M impact | EQUITY | Nov 03, 2026, 09:03 PM UTC
Ardelyx Reports Q3 2026 Financial Results
Ardelyx reported Q3 2026 total product revenue of $125.5 million, up 19% year over year. The supplied body is truncated after an IBSRELA reference.
M impact | EQUITY | Nov 03, 2026, 09:02 PM UTC
Ultragenyx Pharma Reports $173M in Third-Quarter Revenue
M impact | EQUITY | Nov 03, 2026, 09:02 PM UTC
Amgen Reports Third-Quarter 2026 Financial Results
M impact | EQUITY | Nov 03, 2026, 09:02 PM UTC
Ramaco Resources Q3 Revenue $150.1M vs. $140.2M Estimate
Ramaco Resources reported Q3 revenue of $150.1 million, compared with the IBES estimate of $140.2 million.
M impact | EQUITY | Nov 03, 2026, 09:02 PM UTC